← Back to all trials
Recruiting
NCT07164131
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
Conditions: Community-acquired Pneumonia
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE4
Enrollment: 1120
Sponsor: Mayo Clinic
Location: Mayo Clinic in Arizona Scottsdale Arizona
Summary
The purpose of this study is to compare effectiveness and safety of Azithromycin versus Doxycycline in adult patients hospitalized with community acquired pneumonia (CAP) treated with Beta-lactams.
Eligibility Criteria
Inclusion Criteria:
• All adult patients (\>18 years old) admitted with CAP and receiving a beta-lactam antibiotic plus a form of atypical coverage (azithromycin or doxycycline) in the ED within 12 hours of admission.
Exclusion Criteria:
* High clinical suspicion for Legionella pneumonia
* Allergy or contraindication to the use of either azithromycin or doxycycline (usual clinical practice)
* Antibiotics not for CAP
* Pregnant women (based on clinical assessment as part of standard of care)
* Severe CAP as defined by the ATS/IDSA criteria
* Corrected QT prolongation (\> 450 ms in men and \> 460 ms in women)
* Incarcerated individuals (prisoner)
Source: ClinicalTrials.gov (NCT07164131). StuddyBuddy aggregates publicly available trial information.